Stem cell patents after the america invents act.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 25957901.
- Also identified by DOI 10.1016/j.stem.2015.04.015.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Under the newly passed Leahy-Smith America Invents Act (AIA), the U.S. Patent and Trademark Office may hear new challenges to stem cell patents. Here, we explore how the new law affects challenges to stem cell patents, focusing on two recent cases, and discuss the future of stem cell patent disputes.
Medical subject headings
- Biotechnology
- Inventions
- Stem Cell Transplantation
- Stem Cells